The genetics of Corticobasal syndrome

Brain and Nerve

Volumn 65, Issue 1, 2013, Pages 19-30

  Doi, Hiroshi ^a   Tanaka, Fumiaki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Corticobasal degeneration; Corticobasal syndrome; Frontotemporal lobar degeneration; Genetics

Indexed keywords

EIF2AK3 PROTEIN; FTLD PROTEIN; GRN PROTEIN; MAPT PROTEIN; MOBP PROTEIN; PROTEIN DERIVATIVE; PSP PROTEIN; STX6 PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; CORTICOBASAL DEGENERATION; CORTICOBASAL SYNDROME; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE COURSE; FAMILIAL DISEASE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; JAPAN; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW;

BASAL GANGLIA DISEASES; FRONTOTEMPORAL LOBAR DEGENERATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; JAPAN; MUTATION; NEURODEGENERATIVE DISEASES;

EID: 84873861410     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Ballan G, Tison F: A historical case of probable corticobasal degeneration? Mov Disord 12: 1073-1074, 1997 (Pubitemid 27496794)
2. Constantinidis J, Richard J, Tissot R: Pick's disease: histological and clinical correlations. Eur Neurol 11: 208-217, 1974
3. Rebeiz JJ, Kolodny EH, Richardson EP Jr: Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc 92: 23-26, 1967
4. Rebeiz JJ, Kolodny EH, Richardson EP Jr: Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20-33, 1968
5. Gibb WR, Luthert PJ, Marsden CD: Corticobasal degeneration. Brain 112 (Pt 5): 1171-1192, 1989 (Pubitemid 19246372)
6. Riley DE, Lang AE, Lewis A, Resch L, Ashby P, et al: Cortical-basal ganglionic degeneration. Neurology 40: 1203-1212, 1990 (Pubitemid 20244976)
7. Lippa CF, Smith TW, Fontneau N: Corticonigral degeneration with neuronal achromasia. A clinico-pathologic study of two cases. J Neurol Sci 98: 301-310, 1990
8. Paulus W, Selim M: Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol 81: 89-94, 1990 (Pubitemid 20377482)
9. Wakabayashi K, Oyanagi K, Makifuchi T, Ikuta F, Homma A, et al: Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 87: 545-553, 1994 (Pubitemid 24158407)
10. Mori H, Nishimura M, Namba Y, Oda M: Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 88: 113-121, 1994 (Pubitemid 24233241)
11. Feany MB, Dickson DW: Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146: 1388-1396, 1995
12. Komori T, Arai N, Oda M, Nakayama H, Mori H, et al: Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 96: 401-408, 1998
13. Arai T, Ikeda K, Akiyama H, Shikamoto Y, Tsuchiya K, et al: Distinct ¡of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 101: 167-173, 2001 (Pubitemid 32124489)
14. Sergeant N, Wattez A, Delacourte A: Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J Neurochem 72: 1243-1249, 1999 (Pubitemid 29085040)
15. Arai T, Ikeda K, Akiyama H, Nonaka T, Hasegawa M, et al: Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 55: 72-79, 2004 (Pubitemid 38067363)
16. Bergeron C, Pollanen MS, Weyer L, Black SE, Lang AE: Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 40: 893-900, 1996 (Pubitemid 27044607)
17. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS: Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 48: 959-969, 1997
18. Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, et al: Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 53: 795-800, 1999 (Pubitemid 29448302)
19. Tartaglia MC, Sidhu M, Laluz V, Racine C, Rabinovici GD, et al: Sporadic corticobasal syndrome due to FTLD-TDP. Acta Neuropathol 119: 365-374, 2010
20. Miyaji Y, Koyama K, Kurokawa T, Mitomi M, Suzuki Y, et al: Vascular corticobasal syndrome caused by unilateral internal carotid artery occlusion. J Stroke Cerebrovasc Dis, 2012 Aug 28 [Epub ahead of print]
21. Boeve BF: The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study. J Mol Neurosci 45: 350-353, 2011
22. Corticobasal syndrome -. Brain Nerve 64: 462-473, 2012
23. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, et al: Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43: 815-825, 1998 (Pubitemid 28280226)
24. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, et al: Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705, 1998
25. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, et al: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 95: 7737-7741, 1998 (Pubitemid 28293323)
26. Harvey RJ, Skelton-Robinson M, Rossor MN: The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 74: 1206-1209, 2003
27. Ratnavalli E, Brayne C, Dawson K, Hodges JR: The prevalence of frontotemporal dementia. Neurology 58: 1615-1621, 2002 (Pubitemid 34602891)
28. Ikejima C, Yasuno F, Mizukami K, Sasaki M, Tanimukai S, et al: Prevalence and causes of early-onset dementia in Japan: a population-based study. Stroke 40: 2709-2714, 2009
29. Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, et al: Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126: 2016-2022, 2003 (Pubitemid 37059441)
30. Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, et al: Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 65: 1817-1819, 2005
31. Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, et al: The heritability and genetics of frontotemporal lobar degeneration. Neurology 73: 1451-1456, 2009
32. Ikeda M, Ishikawa T, Tanabe H: Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 17: 265-268, 2004 (Pubitemid 38721138)
33. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, et al: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442: 916-919, 2006 (Pubitemid 44285946)
34. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, et al: Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442: 920-924, 2006 (Pubitemid 44285947)
35. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, et al: Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256, 2011
36. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, et al: A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268, 2011
37. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, et al: Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36: 377-381, 2004 (Pubitemid 38437260)
38. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, et al: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37: 806-808, 2005 (Pubitemid 41077105)
39. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC: Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 82: 476-486, 2011
40. Sieben A, Van Langenhove T, Engelborghs S, Martin JJ, Boon P, et al: The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol 124: 353-372, 2012
41. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, et al: TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40: 572-574, 2008 (Pubitemid 351601218)
42. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, et al: TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63: 535-538, 2008 (Pubitemid 351614720)
43. Yokoseki A, Shiga A, Tan CF, Tagawa A, Kaneko H, et al: TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 63: 538-542, 2008 (Pubitemid 351614721)
44. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, et al: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205-1208, 2009
45. Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, et al: Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323: 1208-1211, 2009
46. Huey ED, Ferrari R, Moreno JH, Jensen C, Morris CM, et al: FUS and TDP43 genetic variability in FTD and CBS. Neurobiol Aging 33: 1016. e9-1016. e17, 2012
47. Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, et al: Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477: 211-215, 2011
48. Synofzik M, Maetzler W, Grehl T, Prudlo J, Vom Hagen JM, et al: Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype. Neurobiol Aging 33: 2949. e13-2949. e17, 2012
49. Groen JJ, Endtz LJ: Hereditary Pick's disease: second re-examination of the large family and discussion of other hereditary cases, with particular reference to electroencephalography, a computerized tomography. Brain 105 (Pt 3): 443-459, 1982 (Pubitemid 12004277)
50. Wszolek ZK, Pfeiffer RF, Bhatt MH, Schelper RL, Cordes M, et al: Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-pontonigral degeneration. Ann Neurol 32: 312-320, 1992
51. Sumi SM, Bird TD, Nochlin D, Raskind MA: Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala. Neurology 42: 120-127, 1992
52. Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG: Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 55: 1159-1165, 1994 (Pubitemid 24355570)
53. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, et al: Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann Neurol 41: 706-715, 1997 (Pubitemid 27249175)
54. D'Souza I, Schellenberg GD: Regulation of tau isoform expression and dementia. Biochim Biophys Acta 1739: 104-115, 2005 (Pubitemid 40021805)
55. Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, et al: Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 58: 667-677, 1999 (Pubitemid 29264946)
56. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, et al: Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119: 1-4, 2010
57. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA: Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3: 519-526, 1989
58. Hutton M: Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology 56: S21-S25, 2001
59. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, et al: Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282: 1914-1917, 1998 (Pubitemid 28555275)
60. Hasegawa M, Smith MJ, Goedert M: Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 437: 207-210, 1998 (Pubitemid 28511158)
61. Arrasate M, Perez M, Armas-Portela R, Avila J: Polymerization of tau peptides into fibrillar structures: the effect of FTDP-17 mutations. FEBS Lett 446: 199-202, 1999 (Pubitemid 29127276)
62. Goedert M, Jakes R, Crowther RA: Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett 450: 306-311, 1999 (Pubitemid 29219534)
63. Nacharaju P, Lewis J, Easson C, Yen S, Hackett J, et al: Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett 447: 195-199, 1999 (Pubitemid 29146084)
64. von Bergen M, Barghorn S, Li L, Marx A, Biernat J, et al: Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem 276: 48165-48174, 2001
65. Stanford PM, Shepherd CE, Halliday GM, Brooks WS, Schofield PW, et al: Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 126: 814-826, 2003 (Pubitemid 36372982)
66. van Swieten JC, Bronner IF, Azmani A, Severijnen LA, Kamphorst W, et al: The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo. J Neuropathol Exp Neurol 66: 17-25, 2007 (Pubitemid 46066785)
67. Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, et al: Evidence for a role of the rare p. A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet 21: 3500-3512, 2012
68. Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, et al: Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41: 277-281, 1997 (Pubitemid 27082112)
69. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, et al: Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8: 711-715, 1999 (Pubitemid 29139987)
70. Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, et al: A common inversion under selection in Europeans. Nat Genet 37: 129-137, 2005
71. Di Maria E, Tabaton M, Vigo T, Abbruzzese G, Bellone E, et al: Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 47: 374-377, 2000
72. Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, et al: Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56: 1702-1706, 2001
73. Litvan I, Chism A, Litvan J, Cambon A, Hutton M: H1/H1 genotype influences symptom severity in corticobasal syndrome. Mov Disord 25: 760-763, 2010
74. Evans W, Fung HC, Steele J, Eerola J, Tienari P, et al: The tau H2 haplotype is almost exclusively Caucasian in origin. Neurosci Lett 369: 183-185, 2004 (Pubitemid 39298905)
75. Pittman AM, Myers AJ, Abou-Sleiman P, Fung HC, Kaleem M, et al: Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet 42: 837-846, 2005 (Pubitemid 41598191)
76. Rademakers R, Melquist S, Cruts M, Theuns J, Del-Favero J, et al: High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet 14: 3281-3292, 2005 (Pubitemid 41631302)
77. Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, et al: The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 25: 561-570, 2007
78. Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, et al: Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43: 699-705, 2011
79. Tuite PJ, Clark HB, Bergeron C, Bower M, St George-Hyslop P, et al: Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. Arch Neurol 62: 1453-1457, 2005 (Pubitemid 41352064)
80. Jung HH, Bremer J, Streffer J, Virdee K, Spillantini MG, et al: Phenotypic variation of autosomal-dominant corticobasal degeneration. Eur Neurol 67: 142-150, 2012
81. Masellis M, Momeni P, Meschino W, Heffner R Jr, Elder J, et al: Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 129 (Pt 11): 3115-3123, 2006 (Pubitemid 44684530)
82. Benussi L, Binetti G, Sina E, Gigola L, Bettecken T, et al: A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 29: 427-435, 2008 (Pubitemid 351215590)
83. Liu CJ, Bosch X: Progranulin: a growth factor, a novel TNFR ligand and a drug target. Pharmacol Ther 133: 124-132, 2012
84. van Swieten JC, Heutink P: Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 7: 965-974, 2008
85. Gijselinck I, van der Zee J, Engelborghs S, Goossens D, Peeters K, et al: Progranulin locus deletion in frontotemporal dementia. Hum Mutat 29: 53-58, 2008
86. Shankaran SS, Capell A, Hruscha AT, Fellerer K, Neumann M, et al: Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. J Biol Chem 283: 1744-1753, 2008
87. Smith KR, Damiano J, Franceschetti S, Carpenter S, Canafoglia L, et al: Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet 90: 1102-1107, 2012
88. Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, et al: TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171: 227-240, 2007 (Pubitemid 47342406)
89. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, et al: The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332: 478-484, 2011
90. Martens LH, Zhang J, Barmada SJ, Zhou P, Kamiya S, et al: Progranulin deficiency promotes neuroinflammation and neuron loss following toxininduced injury. J Clin Invest 122: 3955-3959, 2012
91. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, et al: Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17: 3631-3642, 2008
92. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, et al: Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 42: 234-239, 2010
93. Cruchaga C, Graff C, Chiang HH, Wang J, Hinrichs AL, et al: Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch Neurol 68: 581-586, 2011
94. Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, et al: TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 76: 467-474, 2011
95. Sapp P, et al: A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66: 839-844, 2006 (Pubitemid 43739757)
96. Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, et al: Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain 129: 868-876, 2006
97. van Es MA, Veldink JH, Saris CG, Blauw HM, Van Vught PW, et al: Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 41: 1083-1087, 2009
98. Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai SL, et al: Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 9: 978-985, 2010
99. Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, et al: Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 9: 986-994, 2010
100. van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, et al: A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability and intermediate repeats. Hum Mutat, 2012 Oct 30 [Epub ahead of print]
101. Ogaki K, Li Y, Atsuta N, Tomiyama H, Funayama M, et al: Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 33: 2527. e11-2527. e16, 2012
102. Ogaki K, Li Y, Takanashi M, Ishikawa KI, Kobayashi T, et al: Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism Relat Disord, 2012 Jul 18 [Epub ahead of print]
103. Ishiura H, Takahashi Y, Mitsui J, Yoshida S, Kihira T, et al: C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Arch Neurol 69: 1154-1158, 2012
104. Lindquist S, Duno M, Batbayli M, Puschmann A, Braendgaard H, et al: Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clin Genet, 2012 May 31 [Epub ahead of print]
105. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, et al: Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68: 857-864, 2010
106. Abramzon Y, Johnson JO, Scholz SW, Taylor JP, Brunetti M, et al: Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 33: 2231. e1-2231. e6, 2012
107. Dermaut B, Kumar-Singh S, Engelborghs S, Theuns J, Rademakers R, et al: A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 55: 617-626, 2004 (Pubitemid 38544321)
108. Robles A, Sobrido MJ, García-Murias M, Prieto JM, Lema M, et al: Clinical picture of a patient with a novel PSEN1 mutation (L424V). Am J Alzheimers Dis Other Demen 24: 40-45, 2009
109. Chen-Plotkin AS, Yuan W, Anderson C, McCarty Wood E, Hurtig HI, et al: Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations. Neurology 70: 521-527, 2008 (Pubitemid 351653376)
110. Lee W, Simpson M, Ling H, McLean C, Collins S, et al: Characterising the uncommon corticobasal syndrome presentation of sporadic Creutzfeldt-Jakob disease. Parkinsonism Relat Disord, 2012 Aug 31 [Epub ahead of print]
111. Magherini A, Pentore R, Galassi G, Stucchi CM, Capellari S, et al: MV2 subtype of sporadic Creutzfeldt-Jakob disease presenting as corticobasal syndrome. Mov Disord 22: 898-899, 2007 (Pubitemid 46800121)
112. Iwasaki Y, Mori K, Ito M, Nagaoka M, Ieda T, et al: An autopsied case of V180I Creutzfeldt-Jakob disease presenting with panencephalopathic-type pathology and a characteristic prion protein type. Neuropathology 31: 540-548, 2011
113. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, et al: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554, 1998
114. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, et al: Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58: 1803-1809, 2001 (Pubitemid 33044246)
115. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, et al: Classification of primary progressive aphasia and its variants. Neurology 76: 1006-1014, 2011